Abstract
Adenine and uridine nucleotides evoke Ca2+ signals via four subtypes of P2Y receptor in cultured aortic smooth muscle cells, but the mechanisms underlying the different patterns of these Ca2+ signals are unresolved. Cytosolic Ca2+ signals were recorded from single cells and populations of cultured rat aortic smooth muscle cells, loaded with a fluorescent Ca2+ indicator and stimulated with agonists that allow subtype-selective activation of P2Y1, P2Y2, P2Y4, or P2Y6 receptors. Activation of P2Y1, P2Y2, and P2Y6 receptors caused homologous desensitisation, while activation of P2Y2 receptors also caused heterologous desensitisation of the other subtypes. The Ca2+ signals evoked by each P2Y receptor subtype required activation of phospholipase C and release of Ca2+ from intracellular stores via inositol 1,4,5-trisphosphate (IP3) receptors, but they were unaffected by inhibition of ryanodine or nicotinic acid adenine dinucleotide phosphate (NAADP) receptors. Sustained Ca2+ signals were independent of the Na+/Ca2+ exchanger and were probably mediated by store-operated Ca2+ entry. Analyses of single cells established that most cells express P2Y2 receptors and at least two other P2Y receptor subtypes. We conclude that four P2Y receptor subtypes evoke Ca2+ signals in cultured aortic smooth muscle cells using the same intracellular (IP3 receptors) and Ca2+ entry pathways (store-operated Ca2+ entry). Different rates of homologous desensitisation and different levels of receptor expression account for the different patterns of Ca2+ signal evoked by each P2Y receptor subtype.
Similar content being viewed by others
References
House SJ, Potier M, Bisaillon J, Singer HA, Trebak M (2008) The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch 456:769–785
Owens GK, Kumar MS, Wamhoff BR (2004) Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84:767–801
Vallot O, Combettes L, Jourdon P, Inamo J, Marty I, Claret M, Lompre AM (2000) Intracellular Ca2+ handling in vascular smooth muscle cells is affected by proliferation. Pflugers Arch 20:1225–1235
Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, Golovina VA (2008) Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol 295:C779–C790
Thyberg J (1996) Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 169:183–265
Hao H, Gabbiani G, Bochaton-Piallat ML (2003) Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Artero Thromb Vasc Biol 23:1510–1520
Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281–341
Burnstock G (2002) Purinergic signaling and vascular cell proliferation and death. Artero Thromb Vasc Biol 22:364–373
Vial C, Evans RJ (2002) P2X1 receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 62:1438–1445
Govindan S, Taylor EJA, Taylor CW (2010) Ca2+ signalling by P2Y receptors in cultured rat aortic smooth muscle cells. Br J Pharmacol 160:1953–1962
Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440–3450
Erlinge D, Hou M, Webb TE, Barnard EA, Moller S (1998) Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Commun 248:864–870
Chhatriwala M, Ravi RG, Patel RI, Boyer JL, Jacobson KA, Harden TK (2004) Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog. J Pharmacol Exp Ther 311:1038–1043
Jacobson KA, Costanzi S, Ivanov AA, Tchilibon S, Besada P, Gao ZG, Maddileti S, Harden TK (2006) Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors. Biochem Pharmacol 71:540–549
Fricks IP, Maddileti S, Carter RL, Lazarowski ER, Nicholas RA, Jacobson KA, Harden TK (2008) UDP is a competitive antagonist at the human P2Y14 receptor. J Pharmacol Exp Ther 325:588–594
Brinson AE, Harden TK (2001) Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. Ser-333 and Ser-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor. J Biol Chem 276:11939–11948
Robaye B, Boeynaems JM, Communi D (1997) Slow desensitization of the human P2Y6 receptor. Eur J Pharmacol 329:231–236
Kennedy C, Qi AD, Herold CL, Harden TK, Nicholas RA (2000) ATP, an agonist at the rat P2Y4 receptor, is an antagonist at the human P2Y4 receptor. Mol Pharmacol 57:926–931
Brass D, Grably MR, Bronstein-Sitton N, Gohar O, Meir A (2011) Using antibodies against P2Y and P2X receptors in purinergic signaling research. Purinergic Signal 8:61–79
Lesh RE, Nixon GF, Fleischer S, Airey JA, Somlyo AP, Somlyo AV (1998) Localization of ryanodine receptors in smooth muscle. Circl Res 82:175–185
Thai TL, Churchill GC, Arendshorst WJ (2009) NAADP receptors mediate calcium signaling stimulated by endothelin-1 and norepinephrine in renal afferent arterioles. Am J Physiol 297:F510–F516
Taylor CW, Broad LM (1998) Pharmacological analysis of intracellular Ca2+ signalling: problems and pitfalls. Trends Pharmacol Sci 19:370–375
Santonastasi M, Wehrens XH (2007) Ryanodine receptors as pharmacological targets for heart disease. Acta Pharm Sinica 28:937–944
Naylor E, Arredouani A, Vasudevan SR, Lewis AM, Parkesh R, Mizote A, Rosen D, Thomas JM, Izumi M, Ganesan A, Galione A, Churchill GC (2009) Identification of a chemical probe for NAADP by virtual screening. Nat Chem Biol 5:220–226
Brailoiu E, Rahman T, Churamani D, Prole DL, Brailoiu GC, Taylor CW, Patel S (2010) An NAADP-gated two-pore channel targeted to the plasma membrane uncouples triggering from amplifying Ca2+ signals. J Biol Chem 285:38611–38616
Taylor CW, Tovey SC (2010) IP3 receptors: toward understanding their activation. Cold Spring Harb Persp Biol 2:a004010
Peppiatt CM, Collins TJ, Mackenzie L, Conway SJ, Holmes AB, Bootman MD, Berridge MJ, Seo JT, Roderick HL (2003) 2-Aminoethoxydiphenyl borate (2-APB) antagonises inositol 1,4,5-trisphosphate-induced calcium release, inhibits calcium pumps and has a use-dependent and slowly reversible action on store-operated calcium entry channels. Cell Calcium 34:97–108
Missiaen L, Callewaert G, De Smedt H, Parys JB (2001) 2-Aminoethoxydiphenyl borate affects the inositol 1,4,5-trisphosphate receptor, the intracellular Ca2+ pump and the non-specific Ca2+ leak from the non-mitochondrial Ca2+ stores of permeabilized A7r5 cells. Cell Calcium 29:111–116
Goto J, Suzuki AZ, Ozaki S, Matsumoto N, Nakamura T, Ebisui E, Fleig A, Penner R, Mikoshiba K (2010) Two novel 2-aminoethyl diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca2+ entry via STIM proteins. Cell Calcium 47:1–10
Bootman MD, Collins TJ, Mackenzie L, Roderick HL, Berridge MJ, Peppiatt CM (2002) 2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release. FASEB J 16:1145–1150
Lemos VS, Poburko D, Liao CH, Cole WC, van Breemen C (2007) Na+ entry via TRPC6 causes Ca2+ entry via NCX reversal in ATP stimulated smooth muscle cells. Biochem Biophys Res Commun 352:130–134
Syyong HT, Poburko D, Fameli N, van Breemen C (2007) ATP promotes NCX-reversal in aortic smooth muscle cells by DAG-activated Na+ entry. Biochem Biophys Res Commun 357:1177–1182
Iwamoto T, Watano T, Shigekawa M (1996) A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271:22391–22397
Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, Singer HA, Trebak M (2009) Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 23:2425–2437
Broad LM, Cannon TR, Taylor CW (1999) A non-capacitative pathway activated by arachidonic acid is the major Ca2+ entry mechanism in rat A7r5 smooth muscle cells stimulated with low concentrations of vasopressin. J Physiol 517:121–134
Putney JW (2009) Capacitative calcium entry: from concept to molecules. Immunol Rev 231:10–22
Prakriya M, Lewis RS (2001) Potentiation and inhibition of Ca2+ release-activated Ca2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP3 receptors. J Physiol 536:3–19
Peinelt C, Lis A, Beck A, Fleig A, Penner R (2008) 2-Aminoethoxydiphenyl borate directly facilitates and indirectly inhibits STIM1-dependent gating of CRAC channels. J Physiol 586:3061–3073
Bisaillon JM, Motiani RK, Gonzalez-Cobos JC, Potier M, Halligan KE, Alzawahra WF, Barroso M, Singer HA, Jourd'heuil D, Trebak M (2010) Essential role for STIM1/Orai1-mediated calcium influx in PDGF-induced smooth muscle migration. Am J Physiol 298:C993–C1005
Baryshnikov SG, Pulina MV, Zulian A, Linde CI, Golovina VA (2009) Orai1, a critical component of store-operated Ca2+ entry, is functionally associated with Na+/Ca2+ exchanger and plasma membrane Ca2+ pump in proliferating human arterial myocytes. Am J Physiol 297:C1103–C1112
Lewis RS (2007) The molecular choreography of a store-operated calcium channel. Nature 446:284–287
Bolotina VM (2008) Orai, STIM1 and iPLA2β: a view from a different perspective. J Physiol 586:3035–3042
Zeng W, Yuan JP, Kim MS, Choi YJ, Huang GN, Worley PF, Muallem S (2008) STIM1 gates TRPC channels, but not Orai1, by electrostatic interaction. Mol Cell 32:439–448
Liao Y, Erxleben C, Yildirim E, Abramowitz J, Armstrong DL, Birnbaumer L (2007) Orai proteins interact with TRPC channels and confer responsiveness to store depletion. Proc Natl Acad Sci USA 104:4682–4687
Albert AP, Saleh SN, Peppiatt-Wildman CM, Large WA (2007) Multiple activation mechanisms of store-operated TRPC channels in smooth muscle cells. J Physiol 583:25–36
Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ (2005) P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105:3552–3560
Rodriguez-Rodriguez R, Yarova P, Winter P, Dora KA (2009) Desensitization of endothelial P2Y1 receptors by PKC-dependent mechanisms in pressurized rat small mesenteric arteries. Br J Pharmacol 158:1609–1620
Acknowledgements
This work was supported by the Medical Research Council [0700843] and the Wellcome Trust [085295]. We thank Emily Taylor for assistance with experiments and Mohamed Trebak (Albany Medical College, USA) for helpful advice.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 212 kb)
Rights and permissions
About this article
Cite this article
Govindan, S., Taylor, C.W. P2Y receptor subtypes evoke different Ca2+ signals in cultured aortic smooth muscle cells. Purinergic Signalling 8, 763–777 (2012). https://doi.org/10.1007/s11302-012-9323-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-012-9323-6